A Phase 3 prospective, randomized, multicenter, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-Matched, living donor kidney transplants
Clinical Trial Grant
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Medeor Therapeutics, Inc
Start Date
May 21, 2018
End Date
May 4, 2021
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Medeor Therapeutics, Inc
Start Date
May 21, 2018
End Date
May 4, 2021